Latest filing published 05 Sept 2024 for Teladoc Health, Inc., €136k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Andrew Turitz: trading record in brief
Andrew Turitz (senior executive) discloses dealings in Teladoc Health, Inc. to SEC (Form 4). We count 128 filings; the first trade dates from 2 March 2018 and the latest from 4 September 2024.
Every open-market trade on record is a sale: 45 sales worth €13.9M. Besides market trades, the filings include 6 share grants and 77 option exercises. 2024 to date brings no purchases and 6 sales.
On 5 September 2024 came the latest disclosure, an open-market sale for €136k in Teladoc Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Turitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,773 shares@ US$7.2651.9% of flowCommon StockSEC:0001477449-24-000198:0
- 1,056 sharesCommon StockSEC:0001477449-24-000186:0
- 1,056 sharesCommon StockSEC:0001477449-24-000153:0
- 5,647 shares@ US$14.5328.8% of flowCommon StockSEC:0001477449-24-000051:0
- 475 shares@ US$15.062.5% of flowCommon StockSEC:0001477449-24-000041:0
- 1,347 sharesCommon StockSEC:0001477449-23-000099:0
- 1,347 sharesCommon StockSEC:0001477449-23-000043:0
- 1,347 sharesCommon StockSEC:0001415889-23-009203:0
- 1,795 shares@ US$25.91116.7% of flowCommon StockSEC:0001415889-23-004409:0
- 5,389 sharesCommon StockSEC:0001415889-23-004107:0
- 1,974 sharesCommon StockSEC:0001179110-22-002051:0
- 1,205 sharesCommon StockSEC:0001415889-22-002583:0
12 of 12 declarations
